ArticleRadiology case reports2025
Microwave ablation of ectopic mediastinal parathyroid: A case report.
Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Secondary hyperparathyroidism is a common and serious complication of long-term hemodialysis in patients with chronic renal failure. Ectopic parathyroid is caused by migration defects during early development and contamination of parathyroid tissue during parathyroidectomy, which can lead to difficulty in identifying and treating due to the abnormal location of the proliferating parathyroid. This report describes a 41-year-old male patient with chronic renal failure who developed symptomatic hyperparathyroidism after 6 years of regular hemodialysis, with chest CT and parathyroid 99Tcm-MIBI examination showing hyperplasia of ectopic parathyroidism in the upper mediastinum. Subsequently, ultrasound-guided microwave ablation through suprasternal fossa was performed on the patient. After 1 year of postoperative follow-up, the patient's clinical symptoms were significantly improved, and the parathyroid hormone, blood calcium, and blood phosphorus were all controlled to an ideal level. Based on the successful treatment of this case, we believe that ultrasound-guided microwave ablation is an effective alternative for ectopic parathyroid hyperplasia, especially for patients who have difficulty tolerating conventional surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.